Navigation Links
Apples and oranges: Tumor blood vessel cells are remarkably atypical

Contrary to a long-standing assumption that blood vessel cells in healthy tissues and those associated with tumors are similar, a new study unequivocally demonstrates that tumor blood vessel cells are far from normal. The research, published by Cell Press in the September issue of the journal Cancer Cell, identifies tumor-specific blood vessel cells that are atypically stem cell-like and have the potential to differentiate into cartilage- or bone-like tissues.

Although it has been known for some time that tumors can be eradicated in mice by targeting their blood supply, very little is known about the biology of the endothelial cells that line tumor blood vessels (TECs). "A primary assumption of antiangiogenesis therapy is that TECs are normal and derived from nearby, preexisting vessels," explains senior author Dr. Michael Klagsbrun from Children's Hospital Boston and Harvard Medical School. "However, we and other groups have shown that there are several key differences between normal and tumor endothelium."

Dr. Klagsbrun and lead author Dr. Andrew Dudley isolated TECs from mice that spontaneously develop prostate tumors very similar to human prostate cancers. The researchers found that the TECs were multipotent, meaning that they were not fully mature and had the potential to differentiate into multiple different types of cells. The isolated TECs differentiated to form cartilage- and bone-like tissues. "These results suggest that TECs possess a stem/progenitor cell property that distinguishes them from ECs throughout the normal vasculature and undergo atypical differentiation," explains Dr. Klagsbrun.

The researchers went on to demonstrate blood vessel calcification in human and mouse prostate tumor specimens. This bone-like calcification has also been described in diseased blood vessels and is likely to have clinical significance in prostate cancer. "It is possible that calcification of tumor blood vessels could impair blood flow or enable tumor cell entry into the bloodstream, facilitating metastasis," offers Dr. Klagsbrun. "Further, the expression of bone-specific proteins in prostate tumor cells may enable their survival once they reach the bone microenvironment."

Additional research is required to determine how the atypical properties of TECs are associated with the tortuous, leaky vessels characteristic of tumors and whether vascular calcification does indeed encourage tumor cell metastasis. It is also possible that vascular calcification, which is easily discernible histologically, may be a useful diagnostic criterion.


Contact: Cathleen Genova
Cell Press

Related medicine news :

1. Physicians ask EPA, Antibiotics to cure sick apples, or sick children?
2. AUDIO from Medialink and Apple Products Research and Education Council: New Research -- Adults Who Eat Apples, Apple Juice Have Healthier Diets and Lower Risk for Metabolic Syndrome
3. Adults who eat apples, drink apple juice have lower risk for metabolic syndrome
4. Drug Re-Sensitizes Breast Tumors to Treatment
5. Drug/radiation combo may help shrink established tumors
6. Childhood brain tumor traced to normal stem cells gone bad
7. Leading Neurosurgical Center in Moscow Purchases CyberKnife System to Expand Ability to Treat Brain and Spinal Tumors
8. Vitamin C injections slow tumor growth in mice
9. Turned-off cannabinoid receptor turns on colorectal tumor growth
10. Nanoparticles + light = dead tumor cells
11. Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
Post Your Comments:
(Date:11/24/2015)... ... ... Autism Speaks, the world’s leading autism science and advocacy organization, will take ... of people around the world. On December 1, supporters can make an online donation ... the personal stories behind those gifts. , Just as Black Friday and Cyber-Monday ...
(Date:11/24/2015)... Tennessee (PRWEB) , ... November 24, 2015 , ... ... Pharmacy Quality Trend Report . Throughout the past year there have been multiple breakthroughs ... mature state. During this transition, PharmMD has enabled their customers and partners to stay ...
(Date:11/24/2015)... ... ... am so thrilled, as a newbie here, to leave a mark for the entire staff,” ... Makeover® from California Casualty . Stephanie is in her fifth year teaching at Santan ... , “This is such an amazing school and we deserve a space where we can ...
(Date:11/24/2015)... ... November 24, 2015 , ... Add a fresh touch to ... easy and affordable way to bring long-lasting style and cheer to any space. , ... clean the air and keep on giving all year long. , “Holiday plants make ...
(Date:11/24/2015)... ... November 24, 2015 , ... Tudore Tranquility is a new restaurant in Tokyo, ... plant-based fine dining menu that is full of flavorful and creative dishes that exceed ... wedding dinner or a small intimate event. The décor looks stunning with gold and ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... November 24, 2015 --> ... "Spine Biologics Market by Product Type (Bone Graft, Bine Graft ... and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography ... market was valued at $1.90 Billion in 2014 and is ... of 4.4% during the forecast period of 2015 to 2020. ...
(Date:11/24/2015)... FRAMINGHAM, Mass. , Nov. 24, 2015   ... leading innovator of less-invasive, miniaturized circulatory support technologies that ... announced that President and Chief Executive Officer Doug ... Jaffray 27 th Annual Healthcare Conference on December ... being held December 1-2 in New York ...
(Date:11/24/2015)... 2015  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... Directors has declared a special 1 percent stock dividend on ... December 14, 2015, to shareholders of record December 7, 2015.  ... shares of common stock. --> ... strong endorsement of our confidence in Ascendant,s growth strategy as ...
Breaking Medicine Technology: